CooperCompanies stock holds as earnings date approaches
Published on 08/13/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CooperCompanies (US21664P1039) stock closed at $76.73 on August 12, 2026, down 0.12% as traders looked ahead to the next earnings date on September 9, 2026.
Earnings window
The company is expected to report fiscal third-quarter 2026 results on September 9, 2026, with consensus EPS at $1.12 and expected revenue at $1.10 billion, according to a market earnings overview. That places the upcoming print just before a fresh read on CooperCompanies' vision and medical-device businesses.
Analysts now project $1.12 in quarterly EPS for the period ended July 2026, and that estimate has stayed unchanged over the past 30 days. Revenue is forecast at $1.10 billion, which would be 3.8% above the year-ago quarter.
Market context
Recent trading has left the stock at $76.73, while the same earnings overview shows an average price target of $81.36. The gap between those two figures gives the shares a concrete reference point heading into the September 9 release.
CooperCompanies also carries a market value of $14.90 billion in a current stock profile. That gives the name a mid-cap profile even as investors track whether the upcoming quarter supports the existing consensus.
CooperSurgical and CooperVision
CooperCompanies operates through CooperSurgical and CooperVision, with contact lenses and surgical products as its two core businesses. The structure matters because consensus is still anchored to steady demand in both divisions rather than to a single product cycle.
Shares and valuation
CooperCompanies stock remains tied to the earnings setup more than to a one-day catalyst, with the next scheduled report on September 9, 2026. As of August 12, 2026, the shares were at $76.73.
More on CooperCompanies stock
Company: CooperCompanies Inc.
ISIN: US21664P1039
Ticker: COO
Exchange: Nasdaq
Price (as of August 12, 2026, 4:00 p.m. ET): $76.73 USD
Market cap: $14.90 billion
Next earnings date: September 9, 2026
More on the product mix
CooperVision remains the company's most visible consumer-facing line through contact lenses, while CooperSurgical supports the medical-device side of the business.
More on CooperCompanies stock
CooperCompanies stock was valued at $76.73 on August 12, 2026, with the market now keyed to the September 9, 2026 earnings release.
